Late last month, an FDA advisory panel revisited the issue of implant safety, spending two days hearing from manufacturers, researchers, plastic surgeons, and scores of women who say they suffer from autoimmune problems, now referred to as “implant illness.” The panel endorsed a stronger informed-consent process for women getting the devices, but did not support banning any textured brands.